Literature DB >> 23314721

Overview and epidemiology of substance abuse in pregnancy.

Andria D Wendell1.   

Abstract

The use of licit or illicit substances during pregnancy has the potential to produce adverse health effects for the maternal-fetal dyad. In the United States, it is estimated that >4.4% of pregnant women abuse 1 or more substances during pregnancy. Social and environmental factors contribute significantly to increases in the prevalence and complexity of substance abuse disorders. Fear of reprisal prevents many women from accurately reporting substance use patterns and receiving appropriate medical and psychological care. This chapter details the epidemiology and risk factors associated with substance abuse during pregnancy and subsequent complications for the neonate.

Entities:  

Mesh:

Year:  2013        PMID: 23314721     DOI: 10.1097/GRF.0b013e31827feeb9

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  29 in total

1.  Differentiating the Effects of Familial Risk for Alcohol Dependence and Prenatal Exposure to Alcohol on Offspring Brain Morphology.

Authors:  Vinod K Sharma; Shirley Y Hill
Journal:  Alcohol Clin Exp Res       Date:  2017-01-13       Impact factor: 3.455

2.  Maternal mortality and morbidity in the United States: where are we now?

Authors:  Andreea A Creanga; Cynthia J Berg; Jean Y Ko; Sherry L Farr; Van T Tong; F Carol Bruce; William M Callaghan
Journal:  J Womens Health (Larchmt)       Date:  2014-01       Impact factor: 2.681

3.  Validity of Self-Reported Drug Use Information Among Pregnant Women.

Authors:  Mahek Garg; Laura Garrison; Lawrence Leeman; Ajna Hamidovic; Matthew Borrego; William F Rayburn; Ludmila Bakhireva
Journal:  Matern Child Health J       Date:  2016-01

4.  Effects of prenatal alcohol and cigarette exposure on offspring substance use in multiplex, alcohol-dependent families.

Authors:  Jessica W O'Brien; Shirley Y Hill
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

5.  Women and substance use disorders in low- and middle-income countries: A call for advancing research equity in prevention and treatment.

Authors:  Ilze Slabbert; M Claire Greene; Jacqueline S Womersley; Oladiran I Olateju; Matiwos Soboka; Andrine M Lemieux
Journal:  Subst Abus       Date:  2019-11-07       Impact factor: 3.716

6.  Construction of vapor chambers used to expose mice to alcohol during the equivalent of all three trimesters of human development.

Authors:  Russell A Morton; Marvin R Diaz; Lauren A Topper; C Fernando Valenzuela
Journal:  J Vis Exp       Date:  2014-07-13       Impact factor: 1.355

7.  Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.

Authors:  Karen A McQueen; Jodie Murphy-Oikonen; Lindsay Desaulniers
Journal:  Matern Child Health J       Date:  2015-08

8.  Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons.

Authors:  Marian Jarlenski; Colleen L Barry; Sarah Gollust; Amy J Graves; Alene Kennedy-Hendricks; Katy Kozhimannil
Journal:  Am J Public Health       Date:  2017-06-22       Impact factor: 9.308

9.  Effects of prenatal substance exposure on neurocognitive correlates of inhibitory control success and failure.

Authors:  Leslie E Roos; Kathryn G Beauchamp; Katherine C Pears; Philip A Fisher; Elliot T Berkman; Deborah Capaldi
Journal:  Appl Neuropsychol Child       Date:  2016-06-03       Impact factor: 1.493

Review 10.  Substance use in pregnancy: The medical challenge.

Authors:  Kerry-Ann Louw
Journal:  Obstet Med       Date:  2018-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.